RecruitingNot ApplicableNCT05928325

Geriatric Care Survivorship Intervention for Improving the Overall Health of Older Adults With Stage I-III Breast Cancer Who Have Completed Curative Treatment

Implementation of a Geriatric Care Survivorship Intervention in Older Adults Who Have Completed Curative Intent Therapy for Early-Stage Breast Cancer

Sponsor

M.D. Anderson Cancer Center

Enrollment

30 participants

Start Date

Jun 17, 2021

Study Type

INTERVENTIONAL

Conditions

Anatomic Stage II Breast Cancer AJCC v8 Anatomic Stage III Breast Cancer AJCC v8 Anatomic Stage I Breast Cancer AJCC v8

Summary

This trial studies the effect of a geriatric care survivorship intervention in improving the overall health of older adults who have completed curative treatment for stage I-III breast cancer. Geriatric assessment is the complete examination of an elderly individual, which includes a full valuation of the physical and mental conditions, as well as a check of emotional state. Geriatric assessment and survivorship visits after treatment may reduce health burdens and improve the well-being and quality of life of elderly patients with breast cancer. Researchers hope to improve the overall health of older adults who have undergone curative treatment for stage I-III breast cancer.

Eligibility

Min Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study tests a specialized care program — combining geriatric assessment and survivorship support — to help older adults (65+) recover and maintain their health after completing chemotherapy for breast cancer. **You may be eligible if...** - You are 65 years or older - You have been diagnosed with stage I, II, or III breast cancer - You completed your last chemotherapy session within the past 8 weeks - You speak English or Spanish - You are willing and able to participate in all study activities (including an exercise component) **You may NOT be eligible if...** - You have a significant medical condition that your oncologist believes would make exercise unsafe for you Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERComprehensive Geriatric Assessment

Complete geriatric assessments

BEHAVIORALHealth Education

Receive survivorship care education

OTHERMedical Device Usage and Evaluation

Wear activity tracking device

OTHERSupportive Care

Receive geriatric assessment-guided interventions

Locations(1)

M D Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05928325

Related Trials

Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

NCT06058377533 locations

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

NCT05564377479 locations

High Cannabidiol Plant Extract (BRC-001) to Improve Aromatase Inhibitor-Induced Arthralgia in Women With Breast Cancer

NCT065383891 location

Testing Laser Therapy for Treatment of Vaginal Dryness in Survivors of Breast Cancer, The Revitalize Trial

NCT053791531 location

Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer

NCT064340641 location